Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial
Most costs associated with TPT are due to medications and the baseline treatment initiation visit. TPT regimens requiring fewer follow-up visits may reduce overall cost, but the magnitude of this reduction varies by country.
Authors
- Richard Long (ORCID: https://orcid.org/0000-0003-2126-5430)
- Kamila Romanowski (ORCID: https://orcid.org/0000-0002-7027-3579)
- Elias Joseph Jabbour (ORCID: https://orcid.org/0000-0003-4465-6119)
- James C. Johnston (ORCID: https://orcid.org/0000-0002-8879-4989)
- Jonathon R. Campbell (ORCID: https://orcid.org/0000-0003-2341-2166)
- Greg J. Fox (ORCID: https://orcid.org/0000-0002-4085-1411)
- Dick Menzies (ORCID: https://orcid.org/0000-0003-1601-4514)
- Herry Herman (ORCID: https://orcid.org/0000-0002-0136-9753)
- Leila Barss
- Lika Apriani (ORCID: https://orcid.org/0000-0001-9810-8711)
- Yen Pham Ngoc (ORCID: https://orcid.org/0000-0003-1644-4194)
Institutions
- The University of Sydney (AU)
- University of Alberta (CA)
- University of Calgary (CA)
- McGill University Health Centre (CA)
- BC Centre for Disease Control (CA)
- Centre for Global Health Research (CA)
- Institute of Mathematics (VN)
- McGill University (CA)
- Padjadjaran University (ID)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1093/ofid/ofaf563
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- McGill University
- McGill University Health Centre
- Canadian Institutes of Health Research
- Medical Research Council
- National Health and Medical Research Council